Entity usage
Jump to navigation
Jump to search
This page lists pages that use the given entity (e.g. Q42). The list is sorted by descending page ID, so that newer pages are listed first.
Showing below up to 26 results in range #1 to #26.
View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)
- Section 5: Potential explanation for the difference between children and adults in COVID-19 (from DOI: 10.1016/j.clim.2020.108427): Title, Label: en
- Section 3: Mechanism of SARS-CoV-2 invasion into host cells (from DOI: 10.1016/j.clim.2020.108427): Title, Label: en
- Section 2: Epidemiological data of COVID-19 (from DOI: 10.1016/j.clim.2020.108427): Title, Label: en
- Section 1: Introduction (from DOI: 10.1016/j.clim.2020.108427): Title, Label: en
- Section 5: Conclusions (from DOI: 10.1186/s13054-020-02882-x): Title, Label: en
- Section 4: COVID-19: ICU delirium management:potential problems and solutions (from DOI: 10.1186/s13054-020-02882-x): Title, Label: en
- Section 3: COVID-19: Neuro-invasive potential of SARS-nCoV-2 as cause of delirium (from DOI: 10.1186/s13054-020-02882-x): Title, Label: en
- Section 2: COVID-19: Potential factors contributing to ICU delirium (from DOI: 10.1186/s13054-020-02882-x): Title, Label: en
- Section 1: Introduction (from DOI: 10.1186/s13054-020-02882-x): Title, Label: en
- Section 8: Conclusion (from DOI: 10.1007/s11886-020-01292-3): Title, Label: en
- Section 7: Treatments for SARS-CoV-2 Infection (from DOI: 10.1007/s11886-020-01292-3): Title, Label: en
- Section 6: Host-Specific Variations in COVID-19 Immune Response (from DOI: 10.1007/s11886-020-01292-3): Title, Label: en
- Section 3: The Role of Host Immune Response (from DOI: 10.1007/s11886-020-01292-3): Title, Label: en
- Section 2: Biology of SARS-CoV-2 (from DOI: 10.1007/s11886-020-01292-3): Title, Label: en
- Section 1: Introduction (from DOI: 10.1007/s11886-020-01292-3): Title, Label: en
- Section 3: Conclusions and priorities for future research (from DOI: 10.1016/j.jcv.2020.104372): Title, Label: en
- Section 2.3: Congenital and perinatal infections with SARS-CoV-2 (from DOI: 10.1016/j.jcv.2020.104372): Title, Label: en
- Section 2: Is SARS-CoV-2 a congenital or perinatally-acquired pathogen for the neonate? (from DOI: 10.1016/j.jcv.2020.104372): Title, Label: en
- Section 1: Introduction (from DOI: 10.1016/j.jcv.2020.104372): Title, Label: en
- Section 4: Conclusion (from DOI: 10.1007/s11886-020-01293-2): Title, Label: en
- Section 2: SARS-CoV-2 Biology and Clinical Implications (from DOI: 10.1007/s11886-020-01293-2): Title, Label: en
- Section 1: Introduction (from DOI: 10.1007/s11886-020-01293-2): Title, Label: en
- Section 3: Results (from DOI:10.14218/ERHM.2020.00023): Title, Label: en
- Section 2: Methods (from DOI:10.14218/ERHM.2020.00023): Title, Label: en
- Introduction section from DOI: 10.1186/s13613-020-00653-z: Title, Label: en
- Methods section from DOI: 10.1186/s13613-020-00653-z: Title, Label: en